Dr. Seema Rohilla

AI-based ultrasonicator apparatus engineered for the synthesis of niosomes used in cancer treatment

Dr. Seema Rohilla

Dr. Seema Rohilla

About Invention:

The present design relates to an AI-based ultrasonicator apparatus engineered for the synthesis of niosomes used in cancer treatment. The apparatus integrates artificial intelligence with advanced ultrasonic processing to achieve precise, uniform, and efficient formation of niosomal vesicles. Its structural configuration supports automated parameter optimization, including temperature, amplitude, and sonication cycles, enabling reproducible nano-formulation with minimal human intervention. The design ensures enhanced encapsulation efficiency, controlled particle size distribution, and improved stability of the synthesized niosomes. By combining intelligent monitoring systems with a specialized ultrasonication chamber, the apparatus provides a high-performance platform suitable for pharmaceutical research, clinical laboratories, and targeted drug-delivery development. The device offers improved operational accuracy, reduced processing time, and superior formulation quality, demonstrating strong potential for advanced cancer therapeutic applications.

AI-based ultrasonicator apparatus engineered for the synthesis of niosomes used in cancer treatment